Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Finding About Pathogen in Newborns, May Aid Vaccine Development

21.07.2004


A previously unrecognized molecular structure on the surface of the human bacterial pathogen Group B Streptococcus (GBS) – the most common cause of sepsis and meningitis in newborn infants – is described by researchers at the University of California, San Diego (UCSD) School of Medicine in Proceedings of the National Academy of Sciences published online the week of July 19, 2004.

The new discovery has important implications for understanding the mechanism of infection and the design of vaccines to boost human immunity against this potentially devastating pathogen. For example, potential GBS vaccines currently in clinical trials have been developed without this new knowledge, which could possibly impact their effectiveness.

The findings are a collaborative effort between the laboratories of senior author Ajit Varki, M.D., UCSD professor of medicine and cellular and molecular medicine, and co-director of the UCSD Glycobiology Research and Training Center (GRTC), and Victor Nizet, M.D., associate professor of pediatrics, UCSD Division of Infectious Diseases and an attending physician at Children’s Hospital, San Diego. The two groups have been studying the phenomenon in which certain bacterial pathogens coat their surfaces with a thick capsule made of carbohydrate sugars similar to those found on the surface of human cells. In the case of GBS, the bacterial surface capsule contains sialic acid, a sugar that is also displayed prominently on the surface of all cells in the human body. It is believed that GBS uses sialic acid as a form of “molecular mimicry”, where the bacteria disguises itself to look more like human cells and thereby avoids recognition by the immune system.



Using the sophisticated analytical techniques of the UCSD GRTC facility, graduate student Amanda Lewis discovered that the sialic acid of the GBS capsule contained a chemical modification known as O-acetylation, that had been previously overlooked in more than 30 years of published investigations. O-acetylation was detected in every one of 10 different GBS strains examined, with the overall level of modified sialic acid ranging from 5 percent to 55 percent.

“There are a number of reasons why previous researchers have missed this biochemical structure,” said Varki. “Older detection instruments may have been less sensitive, and some of the harsh chemical treatments employed to purify the capsule are known to destroy O-acetylation.”

He added that “since similar chemical treatments are commonly used to isolate GBS capsule for immunization studies, GBS vaccines in development are missing this component of the true or ‘native’ surface structure of the bacteria.”

In other bacterial pathogens where O-acetylation of surface sugars has been studied, it has been shown that the immune system is able to recognize and generate antibodies that specifically react with the O-acetyl modification. In the case of GBS, this possibility is particularly intriguing.

Varki noted that “an unmodified sialic acid-containing structure resembling the GBS capsule sugar, is present on the surface of all human cells; however, an O-acetylated form of this sugar has never, so far, been reported in humans”.

“This observation may have particular relevance for vaccine design,” Nizet added, “since the elimination of O-acetylation in a GBS vaccine potentially destroys a unique biochemical target for immune protection, inadvertently creating a vaccine antigen that more closely resembles normal human tissue structures”.

The discovery of the UCSD group has implications beyond vaccine design, and may also shed new light on the basic biology of the GBS infection. In previous studies, the presence or absence of O-acetylation on sialic acid has been shown to have important effects on the way the sugar can interact with molecules of the immune system such as antibodies and complement. The researchers are currently investigating whether GBS bacteria may use O-acetylation to vary their surface structure and create a “moving target” which is difficult for the human immune system to recognize.

It is estimated that 20 to 30 percent of women of childbearing age are asymptomatic carriers of GBS on their vaginal mucosal surface. Newborns can become infected with GBS that invade through the placenta to initiate infection in the womb, or alternatively, during delivery by exposure to contaminated vaginal fluids. Despite extensive screening of pregnant women and antibiotic prophylaxis during labor, it is estimated that approximately 3,600 newborns develop invasive GBS infections annually in the United States. In addition to neonatal disease, GBS is increasingly associated with serious infections in adult populations such as pregnant women, diabetics, and the elderly.

“The presence of sialic acid in the GBS surface capsule has long been recognized as a critical virulence factor in disease progression,” said Nizet. “A full appreciation of its biochemical complexity will be critical for development of GBS therapeutic or preventative strategies that target this molecule.”

The study was supported by grants to Varki from the National Institutes of Health (NIH) and to Nizet from the Edward J. Mallinckrodt, Jr. Foundation.

| newswise
Further information:
http://www.ucsd.edu
http://cmm.ucsd.edu/varki/biography.html

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>